Poor responder-high responder: The importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols

Human Reproduction

Volumn 16, Issue 4, 2001, Pages 621-626

  Neulen, Joseph ^a   Wenzel, Daniela ^b   Hornig, Carsten ^c   Wünsch, Edda ^a   Weissenborn, Ute ^a   Grunwald, Klaus ^a   Büttner, Reinhard ^a   Weich, Herbert ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c Receptor Ligand Technologies GmbH   (Germany)

Author keywords

Gonadotrophin therapy; Ovarian function; sVEGFR 1; VEGF

Indexed keywords

CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; ANTIBODY DETECTION; ARTICLE; CONCENTRATION RESPONSE; CONCEPTION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICLE FLUID; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OOCYTE; OVARY DISEASE; OVARY FUNCTION;

FALLOPIA; GOES;

EID: 0035071554     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.4.621     Document Type: Article

References (45)

1. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe hyperstimulation syndrome
2. Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome
3. Assessment of the follicular cortisol: Cortisone ratio
4. Evidence for the existence of a novel pregnancy associated soluble variant of the vascular endothelial growth factor receptor, flt-1
5. Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients
6. Gonadotropins and glucocorticoid therapy for 'low responders' - A controlled study
7. Cortisol concentrations in follicular fluid of low responder patients
8. Growth hormone (GH) substitution in hypogonadotropic, GH-deficient women decreases the follicle-stimulating hormone threshold for monofollicular growth
9. In controlled ovarian hyperstimulation, steroid production, oocyte retrieval, and pregnancy rate correlate with gene expression of vascular endothelial growth factor
10. Ovarian stimulation for in vitro fertilization in low-responder patients using pulsatile intravenous follicle stimulating hormone
11. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
12. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes
13. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity
14. High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low responder patients for in vitro fertilization
15. Soluble VEGF receptors
16. Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA
17. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids
18. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development
19. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients
20. Identification of a natural soluble form of the vascular endothelial growth factor receptor, flt-1, and its heterodimerization with KDR
21. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: A preliminary report
22. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells
23. Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome
24. No beneficial effects of human growth hormone therapy in normal ovulatory patients with a poor ovarian response to gonadotrophins
25. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration
26. In vitro release of vascular endothelial growth factor during platelet aggregation
27. Intracytoplasmic sperm injection as a routine indication in low responder patients
28. Use of gonadotrophin-releasing hormone agonists in controlled ovarian hyperstimulation for in vitro fertilization
29. Human chorionic gonadotrophin dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome
30. Vascular endothelial growth factor/vascular permeability factor expression and production by human luteinized granulosa cells: Clinical implications
31. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent
32. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy
33. Endothelial growth factor receptors in human fetal heart
34. Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography
35. The pathogenesis of ovarian hyperstimulation syndrome: In vivo studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial growth factor
36. Urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment
37. Nucleotide sequence and expression of a novel human receptor-type tyrosine gene (flt) closely related to the fms family
38. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
39. Ovarian response to menopausal gonadotrophins in groups of patients with differing basal growth hormone levels
40. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
41. Epigenetic influences on oocyte developmental competence: Perifollicular vascularity and intrafollicular oxygen
42. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: Association with vascular endothelial growth factor levels and perifollicular blood flow characteristics
43. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary
44. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro
45. Vascular endothelial growth factor/vascular permeability factor production by luteinized human granulosa cells in vitro: A paracrine signal in corpus luteum formation